To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the efficacy of ivermectin as a (a) prophylactic and (b) treatment for covid-19.
The Therapeutics Taskforce is continuing to monitor any new, high quality evidence on COVID-19 therapeutics and has been following recent findings on ivermectin.
The Department has monitored a collection of small studies which have now completed and provided some positive signals on the use of ivermectin as a treatment for COVID-19. However, larger scale studies are still needed to confirm the effectiveness and safety of this treatment. The Therapeutics Taskforce is aware that several more studies into ivermectin are set to conclude in the next few months and will continue to monitor these ongoing trials to assess the evidence available on whether ivermectin can prevent and/or reduce the severity of COVID-19.